Cineverse Corp. — Key Metrics
2 years of history · ending 2025-03-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$0
Book Value Per Share
$2
Free Cash Flow Per Share
$1
Cash Per Share
$1
Revenue Per Share
$4
OCF Per Share
$1
Return on Equity
10.6%
Return on Assets
5.5%
Return on Invested Capital
21.7%
Debt to Equity
—
Current Ratio
1.11
Quick Ratio
1.11
Asset Turnover
1.14
Days Sales Outstanding
73.54
Days Payables Outstanding
—
Days Inventory On Hand
—
Cash Conversion Cycle
—
R&D / Revenue
—
SBC / Revenue
2.5%
Capex / Revenue
2.2%
Working Capital
$4M
Net Current Asset Value
$3M
Invested Capital
$39M
OCF / Net Income
4.63
FCF / Net Income
4.63
Accruals Ratio (Sloan)
-18.8%
Net Debt
$-14M
Net Debt / EBITDA
-1.19
Interest Coverage
1.82
Cash Coverage
3.99
Capex Coverage
-9.91
Tangible Common Equity
$14M
TCE / Total Assets
19.0%
Goodwill / Total Assets
9.4%
NOPAT
$8M
Cash ROIC
49.1%
WC / Revenue
4.7%
Capex / D&A
0.28
Reinvestment Rate
-47.9%
Total Payout Ratio
5.7%
Asset Growth vs Revenue Growth
-46.5%
Revenue 5Y CAGR
14.8%
FCF 5Y CAGR
17.5%
EBITDA 5Y CAGR
18.4%
Stock Price (FY-end)
$3
Market Cap
$56M
P/E Ratio
14.96
P/S Ratio
0.72
P/B Ratio
1.45
P/TB Ratio
4.08
P/OCF Ratio
3.23
P/FCF Ratio
3.23
Enterprise Value
$42M
EV / EBITDA
3.61
EV / Sales
0.54
EV / FCF
2.43
FCF Yield
30.9%
Shareholder Yield
-3.0%
Buyback Yield
0.4%
Capex Yield
6.3%
Operating Leverage
64.21
Graham Number
$3
Shares Variation (YoY)
45.4%
Beta (5Y)
1.22
Cost of Equity
10.6%
Cost of Debt (after tax)
—
52W High
$5
52W Low
$1
Trailing Return 1Y
130.7%
Trailing Return 5Y
-47.3%
F-Score (Piotroski)
6.00
Z-Score (Altman)
-7.20
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Stock Price on Earnings Dates
Cineverse Corp. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | -0.10% | 5.70% | -83.70% | 8.00% | 8.70% | 2.60% |
| Foreign Rate Differential | — | — | — | — | — | — |
| Other Adjustments | 0.00% | 0.10% | 0.20% | -0.10% | — | 0.20% |
| SBC (Nondeductible) | -3.40% | -3.40% | 31.50% | -8.30% | -1.00% | 5.90% |
| Valuation Allowance Change | -9.90% | -26.70% | 137.00% | -27.80% | -22.50% | -44.30% |
| Tax Law Change | 0.00% | — | — | — | — | — |
| Effective Tax Rate | -2.20% | 0.50% | -53.20% | -1.30% | -0.10% | 2.70% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $313.0K | −$315.0K | −$788.0K | $119.0K | $10.0K | $106.0K |
| Income Taxes Paid (Cash) | — | — | — | — | — | — |
Cineverse Corp. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.